Listed

Clover Health Investments, Corp.

CLOVNasdaqCIK 1801170FinancialsFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$743.2m, Q2 FY2026
Operating income$28.0m, Q2 FY2026
Net income$28.0m, Q2 FY2026
Clover Health Investments, Corp., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m306Revenue, Q3 FY2023, three months to 2023-09-30$306.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure312Revenue, Q4 FY2023, three months to 2023-12-31$312.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure347Revenue, Q1 FY2024, three months to 2024-03-31$346.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure356Revenue, Q2 FY2024, three months to 2024-06-30$356.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0001801170-25-000204.Report this figure331Revenue, Q3 FY2024, three months to 2024-09-30$331.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure337Revenue, Q4 FY2024, three months to 2024-12-31$337.0m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure462Revenue, Q1 FY2025, three months to 2025-03-31$462.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure478Revenue, Q2 FY2025, three months to 2025-06-30$477.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure497Revenue, Q3 FY2025, three months to 2025-09-30$496.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure488Revenue, Q4 FY2025, three months to 2025-12-31$487.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure749Revenue, Q1 FY2026, three months to 2026-03-31$749.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure743Revenue, Q2 FY2026, three months to 2026-06-30$743.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Gross profit$m70.2Gross profit, Q3 FY2023, three months to 2023-09-30$70.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure64.0Gross profit, Q4 FY2023, three months to 2023-12-31$64.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-14, accession 0001801170-24-000064. Derived: 12-month figure less the 9-month figure.Report this figure81.8Gross profit, Q1 FY2024, three months to 2024-03-31$81.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-05-07, accession 0001801170-24-000102.Report this figure108Gross profit, Q2 FY2024, three months to 2024-06-30$107.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-08-08, accession 0001801170-24-000165.Report this figure81.2Gross profit, Q3 FY2024, three months to 2024-09-30$81.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(33.6)Operating income, Q3 FY2023, three months to 2023-09-30−$33.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure(63.1)Operating income, Q4 FY2023, three months to 2023-12-31−$63.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure(22.7)Operating income, Q1 FY2024, three months to 2024-03-31−$22.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure7.2Operating income, Q2 FY2024, three months to 2024-06-30$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001801170-25-000204.Report this figure(8.8)Operating income, Q3 FY2024, three months to 2024-09-30−$8.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure(21.4)Operating income, Q4 FY2024, three months to 2024-12-31−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure(1.3)Operating income, Q1 FY2025, three months to 2025-03-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure(10.6)Operating income, Q2 FY2025, three months to 2025-06-30−$10.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure(24.4)Operating income, Q3 FY2025, three months to 2025-09-30−$24.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure(49.3)Operating income, Q4 FY2025, three months to 2025-12-31−$49.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure27.3Operating income, Q1 FY2026, three months to 2026-03-31$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure28.0Operating income, Q2 FY2026, three months to 2026-06-30$28.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-06, accession 0001801170-23-000104.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-14, accession 0001801170-24-000064. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Interest expense, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-08-08, accession 0001801170-24-000165.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(41.5)Net income, Q3 FY2023, three months to 2023-09-30−$41.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure(70.5)Net income, Q4 FY2023, three months to 2023-12-31−$70.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure(19.2)Net income, Q1 FY2024, three months to 2024-03-31−$19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure7.4Net income, Q2 FY2024, three months to 2024-06-30$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure(9.2)Net income, Q3 FY2024, three months to 2024-09-30−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure(22.1)Net income, Q4 FY2024, three months to 2024-12-31−$22.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure(1.3)Net income, Q1 FY2025, three months to 2025-03-31−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure(10.6)Net income, Q2 FY2025, three months to 2025-06-30−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure(24.4)Net income, Q3 FY2025, three months to 2025-09-30−$24.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure(49.3)Net income, Q4 FY2025, three months to 2025-12-31−$49.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure27.3Net income, Q1 FY2026, three months to 2026-03-31$27.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure28.0Net income, Q2 FY2026, three months to 2026-06-30$28.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Diluted EPS$ per share(0.09)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-11-06, accession 0001801170-23-000104.Report this figurenot reportednot reportednot reportednot reportednot reported0.00Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure(0.02)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figurenot reportednot reported0.05Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure0.05Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Basic EPS$ per share(0.09)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-11-06, accession 0001801170-23-000104.Report this figurenot reportednot reportednot reportednot reportednot reported0.00Basic EPS, Q1 FY2025, three months to 2025-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure(0.02)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figurenot reportednot reported0.05Basic EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure0.05Basic EPS, Q2 FY2026, three months to 2026-06-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure

Balance sheet

Cash and equivalents$78.3m, FY2025
Shareholders' equity$376.3m, Q2 FY2026
Clover Health Investments, Corp., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m299Cash and equivalents, Q3 FY2023, at 2023-09-30$299.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure123Cash and equivalents, FY2023, at 2023-12-31$122.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure208Cash and equivalents, Q1 FY2024, at 2024-03-31$208.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001801170-24-000102.Report this figure255Cash and equivalents, Q2 FY2024, at 2024-06-30$254.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001801170-24-000165.Report this figure288Cash and equivalents, Q3 FY2024, at 2024-09-30$288.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure195Cash and equivalents, FY2024, at 2024-12-31$194.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figurenot reportednot reportednot reported78.3Cash and equivalents, FY2025, at 2025-12-31$78.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figurenot reportednot reported
Current assets$m916Current assets, Q3 FY2023, at 2023-09-30$915.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001801170-23-000104.Report this figure428Current assets, FY2023, at 2023-12-31$428.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure553Current assets, Q1 FY2024, at 2024-03-31$552.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001801170-24-000102.Report this figure550Current assets, Q2 FY2024, at 2024-06-30$549.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001801170-24-000165.Report this figure433Current assets, Q3 FY2024, at 2024-09-30$432.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure343Current assets, FY2024, at 2024-12-31$343.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure331Current assets, Q1 FY2025, at 2025-03-31$331.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure363Current assets, Q2 FY2025, at 2025-06-30$362.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001801170-25-000204.Report this figure331Current assets, Q3 FY2025, at 2025-09-30$330.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure308Current assets, FY2025, at 2025-12-31$307.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure448Current assets, Q1 FY2026, at 2026-03-31$448.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure485Current assets, Q2 FY2026, at 2026-06-30$485.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Total assets$m685Total assets, Q3 FY2023, at 2023-09-30$685.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure571Total assets, FY2023, at 2023-12-31$570.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure672Total assets, Q1 FY2024, at 2024-03-31$671.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001801170-24-000102.Report this figure674Total assets, Q2 FY2024, at 2024-06-30$674.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001801170-24-000165.Report this figure653Total assets, Q3 FY2024, at 2024-09-30$653.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure581Total assets, FY2024, at 2024-12-31$580.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure584Total assets, Q1 FY2025, at 2025-03-31$583.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure575Total assets, Q2 FY2025, at 2025-06-30$575.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001801170-25-000204.Report this figure560Total assets, Q3 FY2025, at 2025-09-30$559.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure541Total assets, FY2025, at 2025-12-31$541.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure698Total assets, Q1 FY2026, at 2026-03-31$697.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure720Total assets, Q2 FY2026, at 2026-06-30$720.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Current liabilities$m719Current liabilities, Q3 FY2023, at 2023-09-30$718.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001801170-23-000104.Report this figure261Current liabilities, FY2023, at 2023-12-31$261.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure356Current liabilities, Q1 FY2024, at 2024-03-31$356.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001801170-24-000102.Report this figure325Current liabilities, Q2 FY2024, at 2024-06-30$324.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001801170-24-000165.Report this figure280Current liabilities, Q3 FY2024, at 2024-09-30$279.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure214Current liabilities, FY2024, at 2024-12-31$213.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure216Current liabilities, Q1 FY2025, at 2025-03-31$215.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure202Current liabilities, Q2 FY2025, at 2025-06-30$201.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001801170-25-000204.Report this figure193Current liabilities, Q3 FY2025, at 2025-09-30$193.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure209Current liabilities, FY2025, at 2025-12-31$208.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure337Current liabilities, Q1 FY2026, at 2026-03-31$336.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure323Current liabilities, Q2 FY2026, at 2026-06-30$323.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Total liabilities$m738Total liabilities, Q3 FY2023, at 2023-09-30$737.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001801170-23-000104.Report this figure284Total liabilities, FY2023, at 2023-12-31$284.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0001801170-25-000052.Report this figure379Total liabilities, Q1 FY2024, at 2024-03-31$379.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001801170-24-000102.Report this figure349Total liabilities, Q2 FY2024, at 2024-06-30$349.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001801170-24-000165.Report this figure311Total liabilities, Q3 FY2024, at 2024-09-30$310.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure240Total liabilities, FY2024, at 2024-12-31$239.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure248Total liabilities, Q1 FY2025, at 2025-03-31$247.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure231Total liabilities, Q2 FY2025, at 2025-06-30$230.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001801170-25-000204.Report this figure219Total liabilities, Q3 FY2025, at 2025-09-30$218.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure232Total liabilities, FY2025, at 2025-12-31$232.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure358Total liabilities, Q1 FY2026, at 2026-03-31$358.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure344Total liabilities, Q2 FY2026, at 2026-06-30$344.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m322Shareholders' equity, Q3 FY2023, at 2023-09-30$321.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure286Shareholders' equity, FY2023, at 2023-12-31$286.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-K filed 2026-02-27, accession 0001801170-26-000057.Report this figure292Shareholders' equity, Q1 FY2024, at 2024-03-31$292.5m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure325Shareholders' equity, Q2 FY2024, at 2024-06-30$324.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure342Shareholders' equity, Q3 FY2024, at 2024-09-30$342.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure341Shareholders' equity, FY2024, at 2024-12-31$341.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure336Shareholders' equity, Q1 FY2025, at 2025-03-31$336.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure344Shareholders' equity, Q2 FY2025, at 2025-06-30$344.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure341Shareholders' equity, Q3 FY2025, at 2025-09-30$340.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure309Shareholders' equity, FY2025, at 2025-12-31$308.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure339Shareholders' equity, Q1 FY2026, at 2026-03-31$339.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure376Shareholders' equity, Q2 FY2026, at 2026-06-30$376.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure

Cash flow

Operating cash flow$25.2m, Q2 FY2026
Capital expenditure$682.0k, Q2 FY2026
Share repurchases$0, Q2 FY2026
Clover Health Investments, Corp., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(18.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001801170-24-000234. Derived: 9-month figure less the 6-month figure.Report this figure(258)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$258.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure25.9Operating cash flow, Q1 FY2024, three months to 2024-03-31$25.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure44.8Operating cash flow, Q2 FY2024, three months to 2024-06-30$44.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001801170-25-000204. Derived: 6-month figure less the 3-month figure.Report this figure50.0Operating cash flow, Q3 FY2024, three months to 2024-09-30$50.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001801170-25-000275. Derived: 9-month figure less the 6-month figure.Report this figure(85.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$85.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure(16.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$16.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure5.4Operating cash flow, Q2 FY2025, three months to 2025-06-30$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001801170-26-000200. Derived: 6-month figure less the 3-month figure.Report this figure12.1Operating cash flow, Q3 FY2025, three months to 2025-09-30$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001801170-25-000275. Derived: 9-month figure less the 6-month figure.Report this figure(68.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$68.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure108Operating cash flow, Q1 FY2026, three months to 2026-03-31$107.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure25.2Operating cash flow, Q2 FY2026, three months to 2026-06-30$25.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001801170-26-000200. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$243.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-08, accession 0001801170-24-000234. Derived: 9-month figure less the 6-month figure.Report this figure(0.3)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$264.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$445.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure0.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$397.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-08, accession 0001801170-25-000204. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2024, three months to 2024-09-30$399.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001801170-25-000275. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$315.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$185.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure0.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$569.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001801170-26-000200. Derived: 6-month figure less the 3-month figure.Report this figure0.7Capital expenditure, Q3 FY2025, three months to 2025-09-30$692.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001801170-25-000275. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$597.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure0.9Capital expenditure, Q1 FY2026, three months to 2026-03-31$854.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure0.7Capital expenditure, Q2 FY2026, three months to 2026-06-30$682.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001801170-26-000200. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-08, accession 0001801170-24-000234. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure1.8Share repurchases, Q2 FY2024, three months to 2024-06-30$1.8m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-08, accession 0001801170-25-000204. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-07, accession 0001801170-25-000275. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure18.3Share repurchases, Q1 FY2025, three months to 2025-03-31$18.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-07, accession 0001801170-26-000200. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$1.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-07, accession 0001801170-25-000275. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-27, accession 0001801170-26-000057. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-07, accession 0001801170-26-000200. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)545.45m, Q2 FY2026
Clover Health Investments, Corp., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares478Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30477,690,204 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001801170-23-000104.Report this figure479Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31478,805,067 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001801170-24-000102.Report this figure479Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30479,163,752 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001801170-24-000165.Report this figure481Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30480,770,283 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0001801170-24-000234.Report this figure486Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31486,374,644 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001801170-25-000132.Report this figure495Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30495,179,955 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001801170-25-000204.Report this figure490Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30490,180,103 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure497Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31497,056,331 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure509Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30509,043,210 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure513Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30512,743,521 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001801170-25-000275.Report this figure533Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31532,501,448 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001801170-26-000122.Report this figure545Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30545,447,735 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001801170-26-000200.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.